Assertio Holdings (NASDAQ: ASRT)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-04 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.090 | 0.380 | 0.2900 | ||||
REV | 33.060M | 36.538M | 3.478M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Assertio Holdings (NASDAQ: ASRT) through any online brokerage.
Other companies in Assertio Holdings’s space includes: CymaBay Therapeutics (NASDAQ:CBAY), Satsuma Pharmaceuticals (NASDAQ:STSA), Harrow Health (NASDAQ:HROW), Endo International (NASDAQ:ENDP) and NRX Pharmaceuticals (NASDAQ:NRXP).
The latest price target for Assertio Holdings (NASDAQ: ASRT) was reported by BWS Financial on Wednesday, May 18, 2022. The analyst firm set a price target for 6.00 expecting ASRT to rise to within 12 months (a possible 102.70% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Assertio Holdings (NASDAQ: ASRT) is $2.96 last updated Today at May 24, 2022, 7:22 PM UTC.
There are no upcoming dividends for Assertio Holdings.
Assertio Holdings’s Q2 earnings are confirmed for Thursday, August 4, 2022.
There is no upcoming split for Assertio Holdings.
Assertio Holdings is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.